Table 1.
Correlation of PUFA Levels (% of Total Phospholipid FA) with Characteristic | |||||||
---|---|---|---|---|---|---|---|
Characteristic | Mean (SD) | Phospholipid PUFA | Pearson’s r | p | |||
Age yrs | 41.2 (12.4) | DHA% | 0.37 | 0.05 | |||
AA% | 0.51 | 0.004 | |||||
EPA% | 0.20 | 0.30 | |||||
BMI | 26.7 (5.0) | DHA% | 0.03 | 0.87 | |||
AA% | 0.06 | 0.77 | |||||
EPA% | 0.21 | 0.28 | |||||
HDRS score | 21.2 (5.0) | DHA% | − 0.05 | 0.80 | |||
AA% | 0.10 | 0.61 | |||||
EPA% | − 0.14 | 0.47 | |||||
BDI score | 32.1 (9.3) | DHA% | − 0.17 | 0.38 | |||
AA% | 0.04 | 0.85 | |||||
EPA% | − 0.14 | 0.48 | |||||
| |||||||
Phospholipid PUFA Levels (% of Total Phospholipid FA) by Characteristic Status | |||||||
Mean PUFA Level | |||||||
N(%) | PUFA | MDD | BD | t | df | p | |
MDD (vs. BD) | 23 (79) | DHA% | 3.7 (1.1) | 2.4 (1.0) | 2.53 | 27 | 0.02 |
AA% | 11.0 (1.8) | 10.0 (2.6) | 1.12 | 27 | 0.27 | ||
EPA% | 0.6 (0.2) | 0.6 (0.2) | 0.11 | 26 | 0.91 | ||
Male | Female | ||||||
Male | 14 (48) | DHA% | 3.8 (1.2) | 3.1 (1.0) | 1.75 | 27 | 0.09 |
AA% | 10.1 (2.0) | 11.4 (1.9) | −1.74 | 27 | 0.09 | ||
EPA% | 0.6 (0.2) | 0.6 (0.2) | 0.87 | 26 | 0.39 | ||
Smoker | Non-smoker | ||||||
Smoker | 11 (38) | DHA% | 3.0 (1.2) | 3.6 (1.2) | 1.43 | 27 | 0.16 |
AA% | 10.3 (2.3) | 11.1 (1.8) | 1.03 | 27 | 0.31 | ||
EPA% | 0.6 (0.1) | 0.6 (0.3) | 0.94 | 26 | 0.35 |
Bolded values significant at p<0.05. Data expressed in mean (SD) or N(%) as appropriate. Individual phospholipid fatty acid values shown as a percentage of total phospholipid fatty acids. Two-tailed Student’s t-tests compare mean PUFA levels for each categorical variable, in columns labelled “+/− characteristic.” Abbreviations: PUFA, polyunsaturated fatty acid; BMI, body mass index; HDRS, Hamilton Depression Rating Scale (17-item); BDI, Beck Depression Inventory; FA, fatty acid; MDD, Major Depressive Disorder; BD, Bipolar Disorder; DHA, docosahexaenoate; AA, arachidonate.